Originally presented December 2020 at the AMSUS Annual Meeting (virtually)
Once you place your order for this item you will receive two(2) emails, a receipt, and instructions with a link to the CE site
Presenter:
Mulugu Brahmajothi, PhD, MHS
Scientist & PI, Duke University School of Medicine
Duration: 60 minutes
Fee:
AMSUS Member – $0
Non – member – $20
Available: 9/1/2021 – 8/31/2022
CE/CME: 1.0 hour of credit
NOTE- To view the video you must establish a profile on the CE/CME site once you receive the log in link.
If you have completed CE/CME evaluations with AMSUS in the past please log in using the same email address as an existing user.
‘Purchase’ this item in the AMSUS Store
Continuing Education Information
This continuing education activity is provided through collaboration between AMSUS and AffinityCE. This activity provides continuing education credit for physicians, physician assistants, nurses, nurse practitioners, pharmacists, psychologists, and healthcare executives. A statement of participation is available to other attendees.
Brief Description:
Health effects are difficult to discern following exposures to chemical, radioactive, or biological agents when the amount and duration of exposures are unknown. Understanding the individual variations are necessary to create targeted receptor-specific immunotherapies, using blood tests as one of many litmus tests to accurately diagnose and treat Gulf War patients.
Learning Outcomes:
At the conclusion of this activity, participants will be able to:
-
- Review the individual responses to various exposures may differ although in some with relative similarity. Sub-clinical symptoms play a major role in disease progression.
- Explain the crucial patient-reported exposures in understanding symptoms, reviewing patient’s medical records and maintaining the log of symptoms and suspected exposures.
- State the biological effects especially at the cellular and molecular level and review how they play a major role in symptom progression
